News

Retail veteran Rich Juliano helps form new global consultancy group

BY Antoinette Alexander

NAPLES, Fla. — Retail and consumer products industry veterans Rich Juliano, Vince Burke and Jim Gillis have founded Burke • Gillis • Juliano Group, a global consultancy focused on the supermarket, mass retail, convenience, drug and specialty retail trade channels.

Burke • Gillis • Juliano Group offers executive management, market strategy, mergers and acquisitions, private equity, business development, product marketing, trade relations and related services to retailers, suppliers and vendors in the United States and around the world.

At the core of the new company are partners with senior retail and supply leadership experience — Juliano worked at Supervalu, Genuardis Family Markets and Giant Eagle, and Burke comes from Hallmark Cards. Tying the group together is Gillis, who has consulting, P/L management, private equity and both public and private board experience.

Juliano began his career with Giant Eagle, becoming the SVP and GM of the GM/HBC division and then SVP of merchandising and marketing of the Phar-Mor division. He then served as EVP at Thrifty Payless Drug and VP of marketing and merchandising at Genuardis Family Markets. Most recently, he was a senior executive at Supervalu, joining the company as EVP of supply chain services for the Central region and then moving to the Corporate Retail group as VP, GM/HBC and ultimately Group VP of center store merchandising.

“Vince, Jim and I all know retail and CPG inside and out — we’ve been students of the industries for decades. We are now bringing that knowledge and connection base to select clients to help them profitably grow their businesses,” Juliano said.

Burke has more than 34 years of experience in the mass and specialty retail industry. Most recently, Burke served as VP of strategic relationships and business development for Hallmark Cards. Also, Burke has been an active member of the GMDC leadership team.

Gillis is president and CEO of Gillis & Associates, where his clients include TNG/Division of The Jim Pattison Group, Globalworx, Hudson News Retail, Rubicon Global, Synergy Systems and Park City Group. He also sits on several corporate boards and works with private equity firms. Gillis retired as president, COO and co-CEO of Source Interlink Cos., a marketing, merchandising and fulfillment company of entertainment products. He was previously president, CEO and owner of Brand Manufacturing Corp., a designer and manufacturer of retail display systems and was managing partner of Aders, Wilcox, Gillis Group, a developer of trade relationships serving brand marketers and retailers worldwide.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

McKesson increases offer price for Celesio

BY Antoinette Alexander

SAN FRANCISCO and FRANKFURT, Germany — McKesson Corp. has reached an agreement with Franz Haniel & Cie. GmbH, currently representing a 50.01% stake in Celesio, to sweeten the purchase price for its shareholding in Celesio to EUR 23.50 per share.

Accordingly, the price McKesson is offering to all shareholders of Celesio by way of a voluntary public takeover offer increases to EUR 23.50 per share.

McKesson also announced that it has increased the consideration offered under its tender offers for the outstanding convertible bonds of Celesio Finance B.V. to a price equating to a look-through price of EUR 23.50 per underlying Celesio share.

Furthermore, McKesson has reached an agreement with Elliot to acquire their Celesio convertible bonds. The closing of the acquisition of the Celesio convertible bonds from Elliott is subject to the completion of the takeover offer and tender offers.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Bloomberg: Novartis, Merck mulling $5B swap

BY Antoinette Alexander

NEW YORK — Novartis AG is reportedly in talks with Merck to swap its animal health and vaccines businesses for Merck’s OTC business, which includes the Coppertone sunscreen and Claritin allergy medicine brands, according to a Bloomberg report.

People familiar with the matter told Bloomberg that the two drugmakers could each trade about $5 billion in assets. The deal, however, hasn’t been finalized, and Novartis may choose another option.

The swap would make strategic sense for the companie,s as Merck’s OTC business would complement such Novartis consumer items as Lamisil anti-fungal treatment and Triaminic cold medicine. Sources told Bloomberg that Novartis would rather trade the veterinary unit and invest in an area in which it is already a leader.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?